Nordnet Indexfond Global vs SEB Bioteknikfond D

Nordnet Indexfond Global vs SEB Bioteknikfond D

1. Nordnet Indexfond Global

  • Security

    Nordnet Indexfond Global ESG

  • Fee

    0.20%

  • ISIN

    IE00BMTD2G30

  • Holdings

    10

  • Number of owning funds

    2

2. SEB Bioteknikfond D

  • Security

    SEB Bioteknikfond D EUR Lux Utd

  • Fee

    1.69%

  • ISIN

    LU0118405827

  • Holdings

    24

Fund Holdings

We have information about 22 holdings in Nordnet Indexfond Global, where the largest holding is Salesforce.com (0.78), followed by AstraZeneca (0.64) and Merck & Co (0.64). In comparison with SEB Bioteknikfond D, we have 24 holdings where Gilead Sciences is the largest holding (10.04), followed by Vertex (8.8) and Amgen (8.54).

All Holdings

Here we compare the holdings in Nordnet Indexfond Global and SEB Bioteknikfond D.

Nordnet Indexfond Global SEB Bioteknikfond D
1. Salesforce.com Inc
USA
0.78 %
1. Gilead Sciences Inc
USA
10.04 %
2. AstraZeneca
Sweden UK
0.64 %
2. Vertex Pharmaceuticals Inc
8.8 %
3. Merck & Co Inc
Germany
0.64 %
3. Amgen Inc
8.54 %
4. IBM Corp
USA
0.64 %
4. Regeneron Pharmaceuticals Inc
5.09 %
5. GE Aerospace
USA
0.62 %
5. Alnylam Pharmaceuticals Inc
5.07 %
6. McDonald's Corp
USA
0.61 %
6. AstraZeneca ADR
Sweden UK
4.49 %
7. Linde Plc
Ireland
0.61 %
7. Verona Pharma ADR
3.46 %
8. Accenture Plc
Ireland
0.6 %
8. Argenx ADR
2.72 %
9. HSBC Holdings PLC
UK
0.59 %
9. Illumina Inc
2.72 %
10. PepsiCo Inc
USA
0.58 %
10. BioNTech SE
2.41 %
- 11. Madrigal Pharmaceuticals Inc
1.88 %
- 12. BoneSupport AB
Sweden
1.82 %
- 13. BioMarin Pharmaceutical Inc
1.7 %
- 14. Krystal Biotech Inc
1.48 %
- 15. NewAmsterdam Pharma NV
1.46 %
- 16. BridgeBio Pharma Inc
1.45 %
- 17. Cytokinetics Inc
1.4 %
- 18. Ionis Pharmaceuticals Inc
1.37 %
- 19. Xenon Pharmaceuticals
1.37 %
- 20. Insmed Inc
1.32 %
- 21. Onward Medical NV
1.31 %
- 22. Janux Therapeutics Inc
1.3 %
- 23. Structure Therapeutics ADR
1.24 %
- 24. Kymera Therapeutics Inc
1.09 %

The list of fund holdings was last updated on April 17, 2025.